Randomized, phase 2 trial of low-dose cytarabine with or without volasertib in AML patients not suitable for induction therapy

Erstveröffentlichung
2014
Metadata only
Search for full text

Wissenschaftlicher Artikel

Authors
Döhner, Hartmut
Luebbert, Michael
Fiedler, Walter
Fouillard, Loic
Haaland, Alf
et al.
Institutions
UKU. Klinik für Innere Medizin III
Published in
Blood ; 124 (2014), 9. - S. 1426-1433. - ISSN 0006-4971. - eISSN 1528-0020
Link to publication
https://dx.doi.org/10.1182/blood-2014-03-560557
Funding information
Boehringer Ingelheim
GeoMed
Keywords
acute myeloid-leukemia; polo-like kinase; inhibits tumor-growth; advanced solid tumors; antitumor-activity; elderly-patients; cancer-therapy; older patients; open-label; selective inhibitor
Dewey Decimal Group
DDC 610 / Medicine & health
Metadata
Show full item record